Javascript must be enabled to continue!
Respiratory illness virus infections with special emphasis on Covid-19
View through CrossRef
Viruses that emerge pose challenges for treatment options as their
uniqueness would not know completely. In spite of large diversity,
viruses share common characteristics for infection. There are at least
12 different respiratory borne viruses that belong to different virus
taxonomic families. Many of these viruses multiply and cause damage to
the upper and lower respiratory tracts. The description about these
viruses in comparison to each other with reference to their
epidemiology, molecular characteristics, disease manifestations,
diagnosis and treatment is lacking. Such information helps to diagnose,
differentiate and for formulating the control measures at faster pace.
The leading cause of acute illness worldwide are the acute respiratory
infections (ARIs) and are being responsible for nearly 4 million deaths
every year which are mostly in young children and infants. Among the
above ARIs, influenza, respiratory syncytial virus (RSV), parainfluenza
virus type 3 (PIV-3), Streptococcus pneumoniae, Haemophilus influenzae
and corona viruses are the main infectious agents. WHO recognized
respiratory syncytial virus, parainfluenza viruses, coronavirus,
rhinovirus, and human metapneumovirus [non-influenza RNA respiratory
viruses (NIRVs)], as considerable global health burden. Lower
respiratory tract infections are the fourth most common cause of death
globally, after the non-infectious chronic conditions. This review aimed
at presenting the characteristics of different viruses causing the
respiratory infections highlighting the uniqueness of Covid-19. We
expect that this review would help in understanding the similarities and
differences among the closely related viruses causing respiratory
infections and hence to formulate the specific preventive or control
measures.
Title: Respiratory illness virus infections with special emphasis on Covid-19
Description:
Viruses that emerge pose challenges for treatment options as their
uniqueness would not know completely.
In spite of large diversity,
viruses share common characteristics for infection.
There are at least
12 different respiratory borne viruses that belong to different virus
taxonomic families.
Many of these viruses multiply and cause damage to
the upper and lower respiratory tracts.
The description about these
viruses in comparison to each other with reference to their
epidemiology, molecular characteristics, disease manifestations,
diagnosis and treatment is lacking.
Such information helps to diagnose,
differentiate and for formulating the control measures at faster pace.
The leading cause of acute illness worldwide are the acute respiratory
infections (ARIs) and are being responsible for nearly 4 million deaths
every year which are mostly in young children and infants.
Among the
above ARIs, influenza, respiratory syncytial virus (RSV), parainfluenza
virus type 3 (PIV-3), Streptococcus pneumoniae, Haemophilus influenzae
and corona viruses are the main infectious agents.
WHO recognized
respiratory syncytial virus, parainfluenza viruses, coronavirus,
rhinovirus, and human metapneumovirus [non-influenza RNA respiratory
viruses (NIRVs)], as considerable global health burden.
Lower
respiratory tract infections are the fourth most common cause of death
globally, after the non-infectious chronic conditions.
This review aimed
at presenting the characteristics of different viruses causing the
respiratory infections highlighting the uniqueness of Covid-19.
We
expect that this review would help in understanding the similarities and
differences among the closely related viruses causing respiratory
infections and hence to formulate the specific preventive or control
measures.
Related Results
Blogging Illness: Recovering in Public
Blogging Illness: Recovering in Public
As a mode of open access public self-expression, blogs are one form of the unfolding massification of culture (Lovink). Though widely varied in content and style, they are characte...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Epidemiological and clinical profile of viral respiratory infections in children under 5 years at pre‐ and post‐COVID‐19 era in Praia, Cabo Verde
Epidemiological and clinical profile of viral respiratory infections in children under 5 years at pre‐ and post‐COVID‐19 era in Praia, Cabo Verde
AbstractBackgroundThe coronavirus disease‐19 (COVID‐19) pandemic has affected global health, influencing the prevalence of different respiratory pathogens. The aim of this study is...
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
Interactions Between Human Immunodeficiency Virus–1, Hepatitis Delta Virus and Hepatitis B Virus Infections in 260 Chronic Carriers of Hepatitis B Virus
To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, w...
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
The Potential of Medicinal Plants and Bioactive Compounds in the Fight Against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and...

